# Cognitive Decline Linked to Common Pain Drug

## Метаданные

- **Канал:** Neuroscience News
- **YouTube:** https://www.youtube.com/watch?v=VxkHq9EA50o
- **Источник:** https://ekstraktznaniy.ru/video/33992

## Транскрипт

### Segment 1 (00:00 - 02:00) []

Cognitive decline linked to common pain drug. Gabapentin has become one of the go-to treatments for chronic pain, especially low back pain. In part because it's seen as safer and less addictive than opioids. But new research suggests this widely used drug might carry risks we didn't fully appreciate. A large study of medical records found that people who received six or more prescriptions for gabapentin were significantly more likely to develop dementia or mild cognitive impairment within 10 years. The numbers are striking. A 29% higher risk of dementia and an 85% higher risk of mild cognitive impairment compared to those who didn't take the drug. What's even more surprising is how much more vulnerable younger adults appear to be. In those between 35 and 64 years old, the risks of cognitive decline more than doubled or even tripled depending on age group. And the more prescriptions a person had, the greater the risk, showing a clear dose response trend. Now, it's important to note this was an observational study, so it doesn't prove that gabapentin directly causes these problems, but it does raise serious questions about long-term safety and underscores the need for close monitoring of patients who take it regularly. Gabapentin may still play a valuable role in pain management, but this evidence reminds us to weigh the benefits against potential risks and to keep a close eye on cognitive health along the way. This video is based on the research paper risk of dementia following gabapentin prescription in chronic low back pain patients by Chong H Kim at all in regional anesthesia and pain medicine. What do you think about this research? Drop us a comment below. Don't forget to like and subscribe for more neuroscience news updates.